Trials / Sponsors / Enliven Therapeutics
Enliven Therapeutics
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participant CML (Chronic Myelogenous Leukemia), Chronic Phase CML | Phase 1 | 2025-01-23 |
| Active Not Recruiting | ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2 Positive Solid Tumors | Phase 1 | 2024-05-30 |
| Active Not Recruiting | ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer HER2 Mutant Non-small Cell Lung Cancer, HER2-positive Metastatic Breast Cancer, HER2 Gene Mutation | Phase 1 | 2023-03-20 |
| Recruiting | A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Cml | Phase 1 | 2022-05-22 |